medigraphic.com
ISSN 0016-3813 (Print)

2014, Number S2

<< Back Next >>

Gac Med Mex 2014; 150 (S2)

Frequency of peritoneal transport in a population of the Hospital General Regional No. 46, Instituto Mexicano del Seguro Social

Chávez VV, Orizaga CC, Pazarin VHL, Fuentes RF, Parra MR, Aragaki Y, Márquez MI, García CMA, Campos ER

Language: Spanish
References: 23
Page: 186-193
PDF size: 245.53 Kb.


ABSTRACT

Background: The peritoneal equilibration test (PET) is a common test used in the adequacy of peritoneal dialysis (PD). Aim: To determine the frequency of presentation of different types of peritoneal transport in patients on PD ranking with Twardowski, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (INCMNSZ) and Hospital de Especialidades del Instituto Mexicano del Seguro Social Centro Médico Nacional de Occidente (IMSS-HE, CMNO) and establish themselves. Methods: Descriptive and transversal study. Included with PET on PD patients between April 2011 to September 2012; any gender, 16 years or older, in DP minimum of 4 weeks. PEP performed standardized bags of 2.5%. Results: Performed 235 PET. We can classify peritoneal transport with Twardowski in high (H) 34%, high average (HA) 37%, low average (LA) 25%, and low (L) 4% peritoneal transport rates. INCMNSZ percentages H was 34%, HA 32%, LA 23%, and L 11%; using the CMNO HE was H 26%, HA 31%, LA 31%, and L 12%. From our data, the percentage of patients with H was 22%, HA 33%, LA 32%, and L13%. Conclusion: Classifying patients according to type of transport with Twardowski will under-diagnose the low and overestimate high transport, and can alter survival forecasts. (


REFERENCES

  1. Gómez-Dantés O, Sesma S, Becerril VM, Knaul FM, Arreola H, Frenk J. Sistema de salud de México. Salud Pública Mex. 2011;53 supl 2:S220-32.

  2. Obrador GT, García García G, Villa AR, et al. Prevalence of chronic kidney disease in the Kidney Early Evaluation Program (KEEP) México and comparison with KEEP US. Kidney Int. 2010;77(16):S2-S8.

  3. Soriano-Cabrera S. Definición y clasificación de los estadios de la enfermedad renal crónica. Prevalencia. Claves para el diagnóstico precoz. Factores de riesgo de enfermedad renal crónica. Nefrología. 2004;24(6):27-34.

  4. Cueto Manzano AM. Rapid Solute Transport in the peritoneum: physiologic and clinical consequences. Perit Dial Int. 2009;29(S2):S90-5.

  5. Teixidó Planas J. Diálisis peritoneal. Componentes: acceso, membrana peritonreal y soluciones de diálisis. En: Nefrología clínica. Hernando Avendaño L. 3.ª ed. Panamericana; 2009. p. 935-44.

  6. Twardowski ZJ, Nolph KDA, Prowant LBF, Moore HL, Nielsen MP. Peritoneal equilibration test. Perit Dial Bull. 1987:7(3):138-47.

  7. Rojas Campos E, Martínez Ramírez HR, Cortes-Sanabria L, et al. El tipo de transporte peritoneal puede ser diferente en las distintas poblaciones de pacientes en diálisis peritoneal en México. Rev Invest Clin. 2008;60(4):284-91.

  8. Reyes Marín FA, Vargas Becerril A, Ramírez Rodríguez A, Pérez Terrazas H. Prueba de equilibrio peritoneal, análisis de 80 casos, en el Servicio de Nefrología del Hospital Juárez de México de la Secretaría de salud y asistencia. Nefrología Mexicana. 2000;21(1):11-4.

  9. Li PK, Szeto CC, Piraino B, et al. ISPD Guidelines/Recommendations Peritoneal Dialysis - Related Infections Recommendations: 2010 UPDATE. Perit Dial Int. 2010;30(4):393-423.

  10. Sansone G, Cirugeda A, Bajo MA, et al. Actualización de protocolos en la práctica clínica de diálisis peritoneal, año 2004. Nefrologia. 2004;24(5):410-45.

  11. Blake P, Burkart JM, Churchill DN, et al. Recommended clinical practices for maximizing peritoneal dialysis clearances. Perit Dial Int. 1996;16(5):448-56.

  12. Burkart JM. Effect of peritoneal dialysis prescription and peritoneal membrane transport characteristics on nutritional status. Perit Dial Int. 1995;15(5 Suppl):S20-35.

  13. Kandelwal M, Kothai J, Krishnan M, et al. Volume expansion and sodium balance in peritoneal dialysis patients. Part I: Recent concepts in pathogenesis. Adv Perit Dial. 2003;19:36-43.

  14. Churchill DN, Thorpe KE, Nolph KD, Keshaviah PS, Oreopoulos DG, Pagé D. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol. 1998;9(7):1285-92.

  15. Teixidó J. Implicaciones clínicas del transporte peritoneal. Nefrologia. 2000;20(2):53-61.

  16. Brimble KS, Walker M, Margetts P, Kundhal K, Rabbat C. Meta-analysis: peritoneal membrane transport, mortality and tecnique failure in peritoneal dialysis. J Am Soc Nephrol. 2006;17(9):2591-8.

  17. La Milia V. Peritoneal transport testing. J Nephrol. 2010;23(6):633-47.

  18. Cueto-Manzano AM, Díaz-Alvarenga A, Correa-Rotter R. Analysis of the peritoneal equilibration test in Mexico and of factors influencing the peritoneal transport rate. Perit Dial Int. 1999;19(1):45-50.

  19. Paniagua R, Amato D, Vonesh E, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis. ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol. 2002;13(5): 1307-20.

  20. Adequacy of dialysis and nutrition in continuos peritoneal dialysis: association with clinical outcomes. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol. 1996;7(2):198-207.

  21. National Kidney Foundation: NFK-DOQI: Clinical Practice Guidelines for Peritoneal Dialysis Adecuacy. Am J Kidney Dis. 1997;30(Suppl):S67-136.

  22. Correa Rotter R. Evaluación de la dosis adecuada de diálisis. En tratado de diálisis peritoneal. Montenegro Martínez J, Correa-Rotter R, Riella MC (Eds.). 1.ª ed. Barcelona: Elsevier; 2009. p. 229-45.

  23. Portolés J, Corchete E, López-Sánchez P, Coronel F, Ocaña J, Ortiz A. Los pacientes diabéticos tipo 2 presentan peor evolución que los no diabéticos en diálisis peritoneal a expensas de su comorbilidad cardiovascular. Nefrologia. 2009;29(4):336-42.




2020     |     www.medigraphic.com